Challenge Your Exam Readiness With Our Free MLS Practice Questions

Comprehensive and Detailed Explanation:

The direct antiglobulin test (DAT) detects immunoglobulin and/or complement components that are already attached to a patient’s red blood cells in vivo. It is performed by washing patient red cells to remove unbound proteins and then adding antihuman globulin reagent. Agglutination indicates that antibodies or complement are coating the red blood cells.

The DAT is commonly used in the investigation of autoimmune hemolytic anemia, hemolytic transfusion reactions, and hemolytic disease of the fetus and newborn. A positive DAT suggests immune-mediated red cell destruction but must be interpreted with clinical findings.

The indirect antiglobulin test (IAT), in contrast, detects antibodies present in patient serum by allowing them to react with reagent red blood cells in vitro. It is commonly used for antibody screening and compatibility testing.

MLS professionals must understand the difference between DAT and IAT because both involve antiglobulin testing but answer different clinical questions. Proper technique, washing procedures, and reagent handling are essential for reliable results.